|
US4444887A
(en)
*
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US5179017A
(en)
*
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
*
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
*
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6054561A
(en)
*
|
1984-02-08 |
2000-04-25 |
Chiron Corporation |
Antigen-binding sites of antibody molecules specific for cancer antigens
|
|
GB8601597D0
(en)
*
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
*
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5892019A
(en)
*
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
WO1989006692A1
(en)
*
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5225538A
(en)
*
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5413923A
(en)
*
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5605690A
(en)
*
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US5780225A
(en)
*
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
US6075181A
(en)
*
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5314995A
(en)
*
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
US5427908A
(en)
*
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5532351A
(en)
*
|
1990-07-12 |
1996-07-02 |
Arch Development Corporation |
Nucleic acid sequences encoding OMGP
|
|
US5625126A
(en)
*
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
*
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5756096A
(en)
*
|
1991-07-25 |
1998-05-26 |
Idec Pharmaceuticals Corporation |
Recombinant antibodies for human therapy
|
|
US5733743A
(en)
*
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
WO1995014930A1
(en)
*
|
1993-11-23 |
1995-06-01 |
Genentech, Inc. |
Kinase receptor activation assay
|
|
DE4415539C2
(de)
*
|
1994-05-03 |
1996-08-01 |
Osama Dr Dr Med Omer |
Pflanzen mit virustatischer und antiviraler Wirkung
|
|
US5516637A
(en)
*
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
HU226980B1
(en)
*
|
1994-10-25 |
2010-04-28 |
Toyama Chemical Co Ltd |
Use of 1,2-ethanediol derivatives or salts thereof for the preparation of pharmaceutical compositions having nerve growth factor (nfg) potentiator activity
|
|
US5770577A
(en)
*
|
1994-11-14 |
1998-06-23 |
Amgen Inc. |
BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
|
|
US5707829A
(en)
*
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
JP2978435B2
(ja)
*
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
WO1998002540A1
(en)
*
|
1996-07-12 |
1998-01-22 |
Genentech, Inc. |
Chimeric heteromultimer adhesins
|
|
IL127872A0
(en)
*
|
1996-07-19 |
1999-10-28 |
Amgen Inc |
Analogs of cationic proteins
|
|
BR9712978A
(pt)
*
|
1996-09-11 |
2000-04-18 |
Gen Hospital Corp |
Vìrus de dna de não-mamìferos possuindo uma proteìna de revestimento alterada
|
|
US6261545B1
(en)
*
|
1996-09-13 |
2001-07-17 |
Advanced Medicine Research Institute |
Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
|
|
US6420140B1
(en)
*
|
1996-10-11 |
2002-07-16 |
Abgenix, Inc. |
Production of multimeric protein by cell fusion method
|
|
US6156728A
(en)
*
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
ES2242997T3
(es)
*
|
1997-03-14 |
2005-11-16 |
Biogen Idec Inc. |
Metodo para integrar genes en sitios especificos en celulas de mamifero por medio de recombinacion homologa y vectores para realizar el mismo.
|
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
EP1205546B1
(en)
*
|
1997-10-24 |
2005-11-23 |
Genentech, Inc. |
Polypeptide and nucleic acids encoding the same
|
|
US7282482B2
(en)
*
|
1998-04-08 |
2007-10-16 |
The Regents Of The University Of California |
NGF for the prevention of demyelination in the nervous system
|
|
US7034132B2
(en)
*
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
WO2001001748A2
(en)
*
|
1999-07-02 |
2001-01-11 |
Genentech, Inc. |
Peptide compounds that bind her2
|
|
WO2001009318A1
(fr)
*
|
1999-07-29 |
2001-02-08 |
Helix Research Institute |
Genes associes au cancer du foie
|
|
US6680209B1
(en)
*
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
|
US20040252299A9
(en)
*
|
2000-01-07 |
2004-12-16 |
Lemmo Anthony V. |
Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
|
|
US7119165B2
(en)
*
|
2000-01-12 |
2006-10-10 |
Yale University |
Nogo receptor-mediated blockade of axonal growth
|
|
DE60123399T2
(de)
*
|
2000-01-18 |
2007-08-23 |
The Texas A & M University System, College Station |
Pharmazeutische zubereitungen enthaltend beta-turn peptidomimetische zyklische substanzen
|
|
CN101289511A
(zh)
*
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
|
AU2001266787A1
(en)
*
|
2000-06-07 |
2002-01-08 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
US20030162734A1
(en)
*
|
2001-06-28 |
2003-08-28 |
Miller Carol A. |
Modulation of DENN-MADD expression and interactions for treating neurological disorders
|
|
US7223558B2
(en)
*
|
2001-07-11 |
2007-05-29 |
Bristol-Myers Squibb Company |
Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US20050123990A1
(en)
*
|
2001-09-26 |
2005-06-09 |
Incyte Corporation |
Membrane associated proteins
|
|
US7309485B2
(en)
*
|
2001-12-03 |
2007-12-18 |
Children's Medical Center Corporation |
Reducing myelin-mediated inhibition of axon regeneration
|
|
WO2003086289A2
(en)
*
|
2002-04-05 |
2003-10-23 |
Amgen Inc. |
Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
|
|
US6919426B2
(en)
*
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
US7816497B2
(en)
*
|
2002-10-30 |
2010-10-19 |
University Of Kentucky |
Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
|
|
WO2004085648A2
(en)
*
|
2003-03-19 |
2004-10-07 |
Biogen Idec Ma Inc. |
Nogo receptor binding protein
|
|
US7205387B2
(en)
*
|
2003-08-28 |
2007-04-17 |
Agency For Science, Technology And Research |
Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
|
|
JP4969440B2
(ja)
*
|
2004-04-08 |
2012-07-04 |
デビッド， ビー． エイガス， |
疼痛治療のためのＥｒｂＢアンタゴニスト
|
|
PT1776136E
(pt)
*
|
2004-06-24 |
2012-12-05 |
Biogen Idec Inc |
Tratamento de estados que envolvem desmielinização
|
|
US20060009288A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Devos John A |
Conveying information to an interrogator using resonant and parasitic radio frequency circuits
|
|
CA2576193A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Biogen Idec Ma Inc. |
Taj in neuronal function
|
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
AR054260A1
(es)
*
|
2005-04-26 |
2007-06-13 |
Rinat Neuroscience Corp |
Metodos de tratamiento de enfermedades de la neurona motora inferior y composiciones utilizadas en los mismos
|
|
WO2006133164A2
(en)
*
|
2005-06-06 |
2006-12-14 |
Wyeth |
Anti-trkb monoclonal antibodies and uses thereof
|
|
WO2006133353A2
(en)
*
|
2005-06-08 |
2006-12-14 |
The University Of North Carolina At Chapel Hill |
Methods of facilitating neural cell survival using non-peptide and peptide bdnf neurotrophin mimetics
|
|
SI1904104T1
(sl)
*
|
2005-07-08 |
2013-12-31 |
Biogen Idec Ma Inc. |
Protitelesa SP35 in njihova uporaba
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
CA2631181A1
(en)
*
|
2005-12-02 |
2007-06-07 |
Biogen Idec Ma Inc. |
Treatment of conditions involving demyelination
|
|
US20070186296A1
(en)
*
|
2006-02-02 |
2007-08-09 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
|
CN101405297A
(zh)
*
|
2006-02-03 |
2009-04-08 |
惠氏公司 |
Lingo-1结构
|
|
WO2007098283A2
(en)
*
|
2006-02-27 |
2007-08-30 |
Biogen Idec Ma Inc. |
Use of antagonists of maif receptor complex molecules and neurotrophic factors for treatment of neurological diseases and disorders
|
|
JP2009544703A
(ja)
*
|
2006-07-24 |
2009-12-17 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｓｐ３５またはＴｒｋＡアンタゴニストの投与により髄鞘形成、ニューロンの生存および希乏突起膠細胞の分化を促進するための方法
|
|
ATE502960T1
(de)
*
|
2006-11-17 |
2011-04-15 |
Novartis Ag |
Lingo bindende moleküle und pharmazeutische verwendung davon
|
|
CA2672750A1
(en)
*
|
2006-12-20 |
2008-07-03 |
Rinat Neuroscience Corporation |
Trkb agonists for treating autoimmune disorders
|
|
US8128926B2
(en)
*
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
CA2702630C
(en)
*
|
2007-11-08 |
2017-11-21 |
Biogen Idec Ma Inc. |
Use of lingo-4 antagonists in the treatment of conditions involving demyelination
|
|
US8460657B2
(en)
*
|
2008-06-25 |
2013-06-11 |
H. Lundbeck A/S |
Modulation of the TrpV: Vps10p receptor system for the treatment of pain
|
|
DK2982695T3
(da)
*
|
2008-07-09 |
2019-05-13 |
Biogen Ma Inc |
Sammensætninger, der omfatter antistoffer mod lingo eller fragmenter deraf
|
|
WO2010056374A2
(en)
*
|
2008-11-17 |
2010-05-20 |
Veracyte, Inc. |
Methods and compositions of molecular profiling for disease diagnostics
|
|
JP5289986B2
(ja)
*
|
2009-01-20 |
2013-09-11 |
株式会社オーディオテクニカ |
赤外線送信機
|